Literature DB >> 10523309

The mechanism of phosphorylation-inducible activation of the ETS-domain transcription factor Elk-1.

S H Yang1, P Shore, N Willingham, J H Lakey, A D Sharrocks.   

Abstract

Protein phosphorylation represents one of the major mechanisms for transcription factor activation. Here we demonstrate a molecular mechanism by which phosphorylation by mitogen-activated protein (MAP) kinases leads to changes in transcription factor activity. MAP kinases stimulate DNA binding and transcriptional activation mediated by the mammalian ETS-domain transcription factor Elk-1. Phosphorylation of the C-terminal transcriptional activation domain induces a conformational change in Elk-1, which accompanies the stimulation of DNA binding. C-terminal phosphorylation is coupled to activation of DNA binding by the N-terminal DNA-binding domain via an additional intermediary domain. Activation of DNA binding is mediated by an allosteric mechanism involving the key phosphoacceptor residues. Together, these results provide a molecular model for how phosphorylation induces changes in Elk-1 activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523309      PMCID: PMC1171633          DOI: 10.1093/emboj/18.20.5666

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  40 in total

1.  Temporal recruitment of the mSin3A-histone deacetylase corepressor complex to the ETS domain transcription factor Elk-1.

Authors:  S H Yang; E Vickers; A Brehm; T Kouzarides; A D Sharrocks
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Elk-1 interacts with dynein upon serum stimulation but independent of serine 383 phosphorylation.

Authors:  Ozlem Demir; Oya Ari; Isil Aksan Kurnaz
Journal:  Cell Mol Neurobiol       Date:  2011-09-21       Impact factor: 5.046

Review 3.  Molecular mechanisms of ETS transcription factor-mediated tumorigenesis.

Authors:  Adwitiya Kar; Arthur Gutierrez-Hartmann
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-09-25       Impact factor: 8.250

4.  Phosphorylation of the Nicotiana benthamiana WRKY8 transcription factor by MAPK functions in the defense response.

Authors:  Nobuaki Ishihama; Reiko Yamada; Miki Yoshioka; Shinpei Katou; Hirofumi Yoshioka
Journal:  Plant Cell       Date:  2011-03-08       Impact factor: 11.277

5.  Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling.

Authors:  N A Balenga; E Martínez-Pinilla; J Kargl; R Schröder; M Peinhaupt; W Platzer; Z Bálint; M Zamarbide; I G Dopeso-Reyes; A Ricobaraza; J M Pérez-Ortiz; E Kostenis; M Waldhoer; A Heinemann; R Franco
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

6.  Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment.

Authors:  Charles E Foulds; Mary L Nelson; Adam G Blaszczak; Barbara J Graves
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

7.  TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation.

Authors:  Shuping Zhong; Jody Fromm; Deborah L Johnson
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

8.  Interaction of serum response factor (SRF) with the Elk-1 B box inhibits RhoA-actin signaling to SRF and potentiates transcriptional activation by Elk-1.

Authors:  Kasumi Murai; Richard Treisman
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

9.  A neurotoxic phosphoform of Elk-1 associates with inclusions from multiple neurodegenerative diseases.

Authors:  Anup Sharma; Linda M Callahan; Jai-Yoon Sul; Tae Kyung Kim; Lindy Barrett; Minsun Kim; James M Powers; Howard Federoff; James Eberwine
Journal:  PLoS One       Date:  2010-02-02       Impact factor: 3.240

10.  Nuclear entry of activated MAPK is restricted in primary ovarian and mammary epithelial cells.

Authors:  Elizabeth R Smith; Kathy Qi Cai; Jennifer L Smedberg; Melina M Ribeiro; Malgorzata E Rula; Carolyn Slater; Andrew K Godwin; Xiang-Xi Xu
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.